Atrial Fibrillation
The most common variable risk factors for atrial fibrillation are high blood pressure & valvular heart-disease. Additional heart-related risk factors comprise congenital heart disease, coronary artery disease, heart failure and cardiomyopathy. In the evolving world valvular heart disease frequently occurs as a result of rheumatic fever. Lung associated risk factors contain COPD, obesity, and sleep apnea. Other factors comprise tobacco smoking, diabetes mellitus, thyrotoxicosis and excess alcohol intake. However, half of cases are not related with any of these risks. A diagnosis is done by feeling the pulse and may be confirmed using an electrocardiogram.
- Heart failure
- Heart-related complications
- Balloon angioplasty.
- Impella-supported PCI
- Irregular heart rhythms
Related Conference of Atrial Fibrillation
March 23-24, 2026
13th International Conference on Hypertension and Cardiovascular Diseases
London, UK
May 21-22, 2026
13th World Congress on Hypertension, Cardiology, Primary Health and Patient Care
Paris, France
July 23-24, 2026
13th International Conference on Geriatric Cardiology, Cardiovascular Diseases and Palliative Care
Paris, France
Atrial Fibrillation Conference Speakers
Recommended Sessions
- Public Health and Epidemiology
- Stroke
- Anaesthesia and Cardiac Image
- Angiography & Electrocardiography
- Atrial Fibrillation
- Cardiac diagnostics
- Cardiac Emergencies
- Cardiac Nursing
- Cardiac Pharmacology
- Cardio-Oncology
- Cardiovascular Disease
- Cardiovascular Research
- Cardiovascular Toxicology
- Clinical Cardiology case report
- Current Research in Cardiology
- Diabetes, Obesity
- Factors Affecting Heart
- Heart Failure
- Heart Regeneration
- Heart surgery
- Hypertension
- Hypertrophic Cardiomyopathy
- Invasive cardiology
- Molecular Cardiology
- Nuclear Cardiology
- Pediatric Cardiology
- Percutaneous Cardiovascular Interventions
- Preventive cardiology
- Vascular Biology
- Women’s Cardiology
Related Journals
Are you interested in
- Acute Coronary Syndromes (ACS) - Heart Congress_2026 (France)
- Adherence, Self-Management, and Patient Empowerment - Congestive Heart Failure-2026 (France)
- Advanced Cardiac Imaging & Diagnostics - World Heart 2026 (Canada)
- Advanced Echocardiographic Strain Imaging for Early Detection - Congestive Heart Failure-2026 (France)
- Advances in Cardiology and Cardiovascular Medicine - Hypertension Congress-2026 (France)
- Advances in Cardiovascular Imaging - Cardiology-2026 (France)
- Aging and Cardiovascular Health - Heart Congress_2026 (France)
- AI in Cardiology: Innovations and Implications - Heart Congress_2026 (France)
- AI in Heart Drug Discovery - heart-cs-2026 (UAE)
- Arrhythmia Detection - heart-cs-2026 (UAE)
- Arrhythmias and Electrophysiology - World Cardiology-2026 (UK)
- Arrhythmias, Electrophysiology & Pacemaker Technologies - World Heart 2026 (Canada)
- Arrhythmias: Diagnosis and Treatment - Cardiology-2026 (France)
- Artificial Intelligence and Machine Learning in Cardiology - Hypertension Congress-2026 (France)
- Artificial Intelligence and Machine Learning in Cardiology - Cardiology-2026 (France)
- Artificial Intelligence in Cardiology - World Cardiology-2026 (UK)
- Bioengineered Heart Repair & Tissue Engineering - World Heart 2026 (Canada)
- Bioprinting Personalized Cardiac Tissues - Congestive Heart Failure-2026 (France)
- Blockchain for Secure Cardiovascular Data Sharing - Congestive Heart Failure-2026 (France)
- Cardiac Arrhythmias and Electrophysiology - Hypertension Congress-2026 (France)
- Cardiac Complications of Cancer - Heart Congress_2026 (France)
- Cardiac CT and AI-Assisted Angiography - Congestive Heart Failure-2026 (France)
- Cardiac Imaging - Heart Congress_2026 (France)
- Cardiac Imaging Analysis - heart-cs-2026 (UAE)
- Cardiac Imaging and Diagnostic Tools - Hypertension Congress-2026 (France)
- Cardiac Imaging Techniques - World Cardiology-2026 (UK)
- Cardiac Pharmacology - Heart Congress_2026 (France)
- Cardiac Pharmacology & Drug Development - World Heart 2026 (Canada)
- Cardiac Regeneration - Heart Congress_2026 (France)
- Cardiac Rehabilitation - World Cardiology-2026 (UK)
- Cardiac Rehabilitation 2.0: Digital and Virtual Models - Congestive Heart Failure-2026 (France)
- Cardiac Rehabilitation Technology - heart-cs-2026 (UAE)
- Cardiac Surgery Innovations - World Cardiology-2026 (UK)
- Cardiac Surgery Innovations & Robotic Systems - World Heart 2026 (Canada)
- Cardiac Telemedicine - heart-cs-2026 (UAE)
- Cardio-Oncology - Heart Congress_2026 (France)
- Cardio-Oncology - World Cardiology-2026 (UK)
- Cardio-Oncology: Managing Cardiovascular Risk in Cancer Patients - Hypertension Congress-2026 (France)
- Cardiometabolic Health & Preventive Cardiology - World Heart 2026 (Canada)
- Cardiometabolic Health: Diabetes, Obesity & Metabolism - Heart Congress_2026 (France)
- Cardiometabolic Syndrome - World Cardiology-2026 (UK)
- Cardiovascular Disease in Women - Cardiology-2026 (France)
- Cardiovascular Disease, Risk factors and Nutrition - Heart Congress_2026 (France)
- Cardiovascular Genetics: From Bench to Bedside - Cardiology-2026 (France)
- Cardiovascular Imaging: Advances and Applications - Heart Congress_2026 (France)
- Cardiovascular Lifestyle Programs - heart-cs-2026 (UAE)
- Cardiovascular Pharmacology and Therapeutics - Cardiology-2026 (France)
- Cardiovascular Rehabilitation: Enhancing Recovery - Cardiology-2026 (France)
- Cardiovascular Risk Assessment and Prevention - Cardiology-2026 (France)
- Cardiovascular Risk Factors and Metabolic Syndrome - Hypertension Congress-2026 (France)
- Cardiovascular Surgery: Evolving Techniques and Practices - Cardiology-2026 (France)
- Catheterization and Cardiovascular Interventions - Heart Congress_2026 (France)
- Circulating microRNAs and Novel Biomarkers in Diagnosis - Congestive Heart Failure-2026 (France)
- Clinical Data Analysis - heart-cs-2026 (UAE)
- Clinical Guidelines and Evidence-Based Practice - Hypertension Congress-2026 (France)
- Clinical Trials and Research in Hypertension & Cardiology - Hypertension Congress-2026 (France)
- Clinical Trials in Cardiology - World Cardiology-2026 (UK)
- Coronary Artery Disease and Atherosclerosis - Hypertension Congress-2026 (France)
- Coronary Disease Detection - heart-cs-2026 (UAE)
- Coronary Heart Diseases - Heart Congress_2026 (France)
- Coronary Microvascular Dysfunction and Its Role in Angina - Congestive Heart Failure-2026 (France)
- Cross-Disciplinary Approaches: Cardiology, Neurology, and Metabolic Disorders - Congestive Heart Failure-2026 (France)
- Current Research in Cardiology – Future Medicine - Heart Congress_2026 (France)
- Digital Cardiac Rehabilitation - heart-cs-2026 (UAE)
- Digital Health and Telemedicine in Primary Care - Hypertension Congress-2026 (France)
- Digital Health, AI & Remote Cardiac Monitoring - World Heart 2026 (Canada)
- Digital Twin Models - heart-cs-2026 (UAE)
- Digital Twins in Cardiology: Predictive Modeling for Patients - Congestive Heart Failure-2026 (France)
- Emergency and Acute Cardiac Care - World Cardiology-2026 (UK)
- Emergency Cardiac Care & Acute Interventions - World Heart 2026 (Canada)
- Emergency Cardiac Care and Acute Management - Hypertension Congress-2026 (France)
- Emergency Heart Response - heart-cs-2026 (UAE)
- Emerging Tech in Interventional Cardiology - Heart Congress_2026 (France)
- Future Trends and Innovations in Cardiovascular and Primary Health Care - Hypertension Congress-2026 (France)
- Genomics & Precision Cardiology - World Cardiology-2026 (UK)
- Geriatric Cardiology - Heart Congress_2026 (France)
- Geriatric Cardiology and Elderly Care - Hypertension Congress-2026 (France)
- Global Cardiovascular Health Challenges - Cardiology-2026 (France)
- Global Health and Heart Disease - Heart Congress_2026 (France)
- Global Heart Health, Policies & Public Awareness - World Heart 2026 (Canada)
- Heart Attack Prediction - heart-cs-2026 (UAE)
- Heart Failure and Cardiomyopathies - Heart Congress_2026 (France)
- Heart Failure and Cardiomyopathy - Hypertension Congress-2026 (France)
- Heart Failure Management - World Cardiology-2026 (UK)
- Heart Failure Management & Therapeutic Advances - World Heart 2026 (Canada)
- Heart Failure Management: Innovations in Treatment - Cardiology-2026 (France)
- Heart Failure Prediction - heart-cs-2026 (UAE)
- Heart Health Education Platforms - heart-cs-2026 (UAE)
- Heart Health in Diabetes - heart-cs-2026 (UAE)
- Heart Rhythm Monitoring Devices - heart-cs-2026 (UAE)
- Heart Risk Prediction - heart-cs-2026 (UAE)
- Hypertension: Diagnosis, Monitoring, and Management - Hypertension Congress-2026 (France)
- Immunomodulatory Approaches in Heart Failure Management - Congestive Heart Failure-2026 (France)
- Implantable Cardioverter-Defibrillator (ICD) - Heart Congress_2026 (France)
- Inflammation and Immune Response in Angina and Heart Failure - Congestive Heart Failure-2026 (France)
- Integrative and Complementary Cardiology - Hypertension Congress-2026 (France)
- Integrative Medicine for Heart Disease - Heart Congress_2026 (France)
- Interventional Cardiology - World Cardiology-2026 (UK)
- Interventional Cardiology & Structural Heart Disease - World Heart 2026 (Canada)
- Interventional Cardiology and Heart Surgery - Heart Congress_2026 (France)
- Interventional Cardiology and Surgical Innovations - Hypertension Congress-2026 (France)
- Interventional Cardiology: New Frontiers - Cardiology-2026 (France)
- Lifestyle Health Apps - heart-cs-2026 (UAE)
- Lifestyle Medicine and Non-Pharmacological Approaches - Hypertension Congress-2026 (France)
- Mental Health, Depression, and Anxiety in Cardiac Patients - Congestive Heart Failure-2026 (France)
- Metabolic Remodeling in Failing Hearts - Congestive Heart Failure-2026 (France)
- Molecular Imaging in Cardiovascular Diseases - Congestive Heart Failure-2026 (France)
- Myocardial Fibrosis: Mechanisms and Clinical Implications - Congestive Heart Failure-2026 (France)
- Nanomedicine for Targeted Cardiac Drug Delivery - Congestive Heart Failure-2026 (France)
- Neurohormonal Pathways in Heart Failure: New Targets for Therapy - Congestive Heart Failure-2026 (France)
- Next-Generation Antiplatelet and Antithrombotic Strategies - Congestive Heart Failure-2026 (France)
- Next-Generation Implantable Hemodynamic Sensors - Congestive Heart Failure-2026 (France)
- Non-Invasive Hemodynamic Monitoring in Heart Failure Patients - Congestive Heart Failure-2026 (France)
- Novel Lipid-Lowering Therapies and Cardiovascular Outcomes - Congestive Heart Failure-2026 (France)
- Nutrition and Lifestyle Modifications in Cardiovascular Health - Cardiology-2026 (France)
- Occupational and Environmental Cardiology Risks - Hypertension Congress-2026 (France)
- Palliative and End-of-Life Care in Advanced Heart Failure - Congestive Heart Failure-2026 (France)
- Patient-Centered Care and Shared Decision Making - Hypertension Congress-2026 (France)
- Pediatric and Congenital Heart Disease - Cardiology-2026 (France)
- Pediatric Cardiology - World Cardiology-2026 (UK)
- Pediatric Cardiology & Congenital Heart Conditions - World Heart 2026 (Canada)
- Pediatric Cardiology and Congenital Heart Disease - Hypertension Congress-2026 (France)
- Pediatric Cardiology: Current Perspectives - Heart Congress_2026 (France)
- Pediatric Cardiology: Current Perspectives - Heart Congress_2026 (France)
- Peripartum Cardiomyopathy and Women’s Heart Health - Congestive Heart Failure-2026 (France)
- Pharmacological Advances in Cardiovascular Therapy - Hypertension Congress-2026 (France)
- Pharmacotherapy: Latest Developments - Heart Congress_2026 (France)
- Point-of-Care Diagnostics in Low-Resource Settings - Congestive Heart Failure-2026 (France)
- Precision Medicine in Cardiology - Heart Congress_2026 (France)
- Preventive Cardiology - World Cardiology-2026 (UK)
- Primary Health Care and Preventive Cardiology - Hypertension Congress-2026 (France)
- Psychology and Cardiovascular Well-being - Heart Congress_2026 (France)
- Public Health, Epidemiology, and Cardiovascular Disease Prevention - Hypertension Congress-2026 (France)
- Pulmonary Hypertension and Venous Thromboembolism - Heart Congress_2026 (France)
- Regenerative Cardiology - World Cardiology-2026 (UK)
- Regenerative Cardiology & Stem Cell Therapies - World Heart 2026 (Canada)
- Remote Heart Monitoring - heart-cs-2026 (UAE)
- Right Heart Failure and Pulmonary Hypertension: Dual Challenges - Congestive Heart Failure-2026 (France)
- RNA-Based Therapeutics in Cardiovascular Disease - Congestive Heart Failure-2026 (France)
- Rural and Underserved Populations: Bridging the Gap in Care - Congestive Heart Failure-2026 (France)
- Secure Heart Data - heart-cs-2026 (UAE)
- Smart Blood Pressure Monitoring - heart-cs-2026 (UAE)
- Smart Implantable Devices - heart-cs-2026 (UAE)
- Sports Cardiology and Exercise-Induced Cardiac Risk - Congestive Heart Failure-2026 (France)
- Stem Cells for Heart Regeneration - Heart Congress_2026 (France)
- Stroke Risk Assessment - heart-cs-2026 (UAE)
- Telecardiology & Digital Tools - World Cardiology-2026 (UK)
- The Future of Cardiovascular Research: From Innovation to Implementation - Cardiology-2026 (France)
- Valvular Heart Diseases - World Cardiology-2026 (UK)
- Vascular Medicine & Endovascular Interventions - World Heart 2026 (Canada)
- Virtual & Augmented Reality in Cardiac Training and Therapy - Congestive Heart Failure-2026 (France)
- Virtual Heart Assistants - heart-cs-2026 (UAE)
- Wearable Heart Monitors - heart-cs-2026 (UAE)
- Women’s Cardiovascular Health - Hypertension Congress-2026 (France)
- Women’s Cardiovascular Health - World Cardiology-2026 (UK)
- Women’s Heart Health & Hormonal Influences - World Heart 2026 (Canada)